[HTML][HTML] Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A …

C Hamel, S Coppus, J van den Berg, E Hink… - …, 2021 - thelancet.com
… This is reflected by different recommendations in international guidelines. … At day three
(36–48 h later), two doses of misoprostol 400 μg orally (four hours apart) were taken at home. …

[HTML][HTML] Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded …

J van den Berg, CC Hamel, MP Snijders… - BMC pregnancy and …, 2019 - Springer
medical abortion aftermisoprostol (two or three doses of 400 μg) has been reported to be
similar in success rates as a protocol using 800 μg at once [20, 44]. Since a split-dose regimen

[HTML][HTML] Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis

T Shimels, M Getnet, M Shafie, L Belay - Frontiers in Global Women's …, 2023 - frontiersin.org
mifepristone plus misoprostol regimen with misoprostol alone in the medical abortion of first
… The study employed a crossover design with three treatment arms that included the groups …

[HTML][HTML] Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled …

JJ Chu, AJ Devall, LE Beeson, P Hardy, V Cheed… - The Lancet, 2020 - thelancet.com
… published in 2019 identified three relevant studies, including a total of … medical management
of missed miscarriage using the combined mifepristone and misoprostol treatment regimen, …

[HTML][HTML] Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic …

FA Abubeker, A Lavelanet, MI Rodriguez, C Kim - BMC women's health, 2020 - Springer
… Thirty-three studies composed of 22,275 participants were … Combined regimens using
mifepristone and misoprostol had lower … studies comparing medical regimens beyond mifepristone

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan

I Platais, T Tsereteli, G Grebennikova… - International Journal of …, 2016 - Elsevier
… A comparative, non-randomized study was undertaken at three clinics in Kazakhstan … The
primary goal of this study was to estimate the efficacy of abortion regimen. Successful abortion …

[HTML][HTML] … approaches in addition to a pain control regimen for early medical abortion< 63 days' gestation with mifepristone and misoprostol: study protocol for a …

MV Dragoman, D Grossman, N Kapp, NM Huong… - Reproductive health, 2016 - Springer
… women’s pain with early medical abortion (EMA, generally … by one-third of all women
undergoing medical abortion [14]. … for use with EMA in international and national guidelines, …

[HTML][HTML] Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss

CC Hamel, MPLM Snijders, SFPJ Coppus… - Plos one, 2022 - journals.plos.org
medical treatment with placebo followed by misoprostol to be … design varies substantially,
regarding medication regimen, applying … three weeks higher in our study. Of course, the …

[HTML][HTML] A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries

LJ Frye, C Kilfedder, J Blum, B Winikoff - Contraception, 2020 - Elsevier
Three (43%) mifepristone products recommended a 600 mg … acceptable regimens for medical
abortion with misoprostol … in medical abortion product packages obtained during a global

Systematic review of the effectiveness, safety, and acceptability of mifepristone and misoprostol for medical abortion in low-and middle-income countries

I Ferguson, H Scott - Journal of Obstetrics and Gynaecology Canada, 2020 - Elsevier
research on mifepristone and misoprostol is from high-income countries, but more recent
studiesmifepristone and misoprostol for medical abortion for women in low-resource settings. …